BÖLEK, H. Et Al. 2025. Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS). European Journal of Cancer , vol.217 .

BÖLEK, H., Yazgan, S. C., Ceylan, F., Esteban-Villarrubia, J., Arslan, C., Kuş, T., ... Tural, D.(2025). Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS). European Journal of Cancer , vol.217.

BÖLEK, HATİCE Et Al. "Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)," European Journal of Cancer , vol.217, 2025

BÖLEK, HATİCE Et Al. "Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)." European Journal of Cancer , vol.217, 2025

BÖLEK, H. Et Al. (2025) . "Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)." European Journal of Cancer , vol.217.

@article{article, author={HATİCE BÖLEK Et Al. }, title={Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)}, journal={European Journal of Cancer}, year=2025}